Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Autism
Interventions
DRUG

Omega 3 fatty acids

The study will start with low doses and based on the weight of the individual the dosage will be increased biweekly.

OTHER

Placebo

Same dosage as that of omega 3 fatty acids

Trial Locations (1)

08854

University Behavioral Health Care Building, UMDNJ-RWJMS, Piscataway

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of Medicine and Dentistry of New Jersey

OTHER

NCT00467818 - Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders | Biotech Hunter | Biotech Hunter